Combine Hormone Intelligence™ for Perimenopause with Oura Insights — in the Mira App
Track symptoms and help define your fertility stage
Monitor ovulation during perimenopause
Hormones + Oura temperature trends and sleep data together

Combine real-time data from both Mira and Oura to determine your fertility stage, support conception, and clarify perimenopause symptoms.

Why Connect Oura and Mira?
Oura shows you what your body is doing. Mira shows you why.
Symptom monitoring
Ovulation confirmation
Cycle-by-cycle patterns
Clinical confidence
Oura Alone
Tracks temperature trends, sleep scores and stress patterns
Estimates ovulation from temperature trends
Identifies recurring temperature trends and sleep scores
Helps you monitor symptoms
Mira Alone
Links symptoms to hormone levels
Confirms that ovulation still occurs by PdG levels
Provides real-time hormone mapping
Helps identify hormone irregularities
How Mira and Oura work together
84% of women 35+ felt relief after defining their fertility stage with Mira
Mira uses the same science trusted in fertility clinics.
As accurate as blood tests
Works for irregular cycles & hormone imbalances
Smart AI personalizes your results
Get Mira
Navigate perimenopause with science


Track 4 key hormones to assess ovulation patterns, detect anovulation, and gain insight into your fertility stage.

Mira helps identify hormonal changes that could be causing or intensifying symptoms—so you can finally address the root cause.

See your unique Hormonal Fingerprint™ with accurate readings even with irregular cycles.
Get Mira

Mira helps you through your unique challenges
Over 250,000 women worldwide trust Mira’s technology
Mira is the fastest, smartest way to help you get clarity.
Real, certified lab‑grade technology—right at home.
FDA-Registered
MDSAP Certified
ISO 13485
Get Mira
¹ Based on a 2024 pilot study by Mira and Pelex Med: 36 IVF candidates TTC >1 year, 44% conceived within 2 months using Mira tracking + Pelex support. Results are preliminary and not peer-reviewed. For comparison, CDC reports a 42% success rate per IVF transfer. “10x faster” refers to Mira's 44% rate vs. ~4% for 2 months from typical use of the calendar method (source). Individual outcomes may vary.
² WHO, 2023 infertility report: 1 in 6 people globally affected. (source)
³ Moglia et al., BMC Women’s Health (2016): “83% of menstrual‑tracking app users inaccurately predicted their fertile window.”
⁴ Stanford JB et al., Human Reproduction**:** “Mistiming intercourse outside the true fertile window can reduce conception likelihood by up to 50%.”
⁵ Based on a 2025 lab study by MiraLabs comparing Mira to other popular at-home fertility trackers for LH, FSH, E3G, and PdG. “7× more accurate” refers to average alignment with lab results (range 2×-18× for different hormones); “3× more reliable” refers to the average improvement in linearity (range from 1-4× for E3G to 4-6× for LH); and “up to 6× more sensitive” is based on lower detection limits (range from 1-2× for PdG to 6× for E3G). Individual results may vary. Mira is not a diagnostic or contraceptive device.
















